• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int Immunopharmacol . SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis - An updated review

tetano

Editor, Senior Moderator
Int Immunopharmacol


. 2021 Feb 25;95:107493.
doi: 10.1016/j.intimp.2021.107493. Online ahead of print.
SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis - An updated review


Eijaz Ahmed Bhat[SUP] 1 [/SUP], Johra Khan[SUP] 2 [/SUP], Nasreena Sajjad[SUP] 3 [/SUP], Ahmad Ali[SUP] 4 [/SUP], Fahad M Aldakeel[SUP] 5 [/SUP], Ayesha Mateen[SUP] 5 [/SUP], Mohammed S Alqahtani[SUP] 6 [/SUP], Rabbani Syed[SUP] 6 [/SUP]



Affiliations

Abstract

The novel coronavirus disease (COVID-19) a global pandemic outbreak is an emerging new virus accountable for respiratory illness caused by SARS-CoV-2, originated in Wuhan city, Hubei province China, urgently calls to adopt prevention and intervention strategies. Several viral epidemics such as severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 to 2003 and H1N1 influenza in 2009 were reported since last two decades. Moreover, the Saudi Arabia was the epicenter for Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012. The CoVs are large family with single-stranded RNA viruses (+ssRNA). Genome sequence of 2019-nCoV, shows relatively different homology from other coronavirus subtypes, categorized in betacoronavirus and possibly found from strain of bats. The COVID-19 composed of exposed densely glycosylated spike protein (S) determines virus binding and infiltrate into host cells as well as initiate protective host immune response. Recently published reviews on the emerging SARS-CoV-2 have mainly focused on its structure, development of the outbreak, relevant precautions and management trials. Currently, there is an urgency of pharmacological intervention to combat this deadly infectious disease. Elucidation of molecular mechanism of COVID-19 becomes necessary. Based on the current literature and understanding, the aim of this review is to provide current genome structure, etiology, clinical prognosis as well as to explore the viral receptor binding together functional insight of SARS-CoV-2 infection (COVID-19) with treatment and preventive measures.

Keywords: COVID-19; Coronavirus; MERS-CoV; SARS-CoV-2; Vaccine.
 
Back
Top Bottom